Skip to content
akaturk Academic measurement
2025 SJR Q4 JCR Q4 · 0,3 OA 4 matched articles ESCI

Journal detail

Medicni Perspektivi

Publisher
Dnipro State Medical University
Country
Ukraine · Eastern Europe
Type
journal
ISSN
  • 23070404
  • 27864804
Scopus 0,133 SJR
Scopus Q4 SJR Q
WoS Q4 JCR Q
WoS 0,3 JIF
Scopus 10 H-Index

Integrated evaluation

Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.

WoS / JCR data covers 1997 onward.

Scopus

Scopus · Scimago

  • SJR 0,133
  • Quartile Q4
  • H-Index 10
  • Cites/doc 0,49
  • Docs (3y) 336
  • Cites (3y) 138

Clarivate

Web of Science · JCR · 2025

  • JCR Q Q4
  • JIF 0,3
  • 5Y JIF 0,2
  • JCI 0,07

WoS indexes

  • ESCI

Subject classification

Categories (SJR)

  • Medicine (miscellaneous) Q4

Areas

  • Medicine

WoS categories

  • Medicine, General & Internal

Yearly quartile comparison

Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.

WoS / JCR data covers 1997 onward.

Note: JCR Q, JIF, 5Y JIF, JCI, and JCI Q are blank before 1997 — WoS/JCR data on this site starts in 1997.
Year SJR Q JCR Q (1997+) SJR JIF (1997+) 5Y JIF (1997+) JCI (1997+) JCI Q (1997+) H-Index
2025 Q4 Q4 0,133 0,3 0,2 0,07 Q4 10
2024 Q4 Q4 0,136 0,2 0,1 0,07 Q4 7
2023 Q4 Q4 0,122 0,2 0,1 0,04 Q4 7
2022 Q4 0,111 0,1 0,1 0,03 Q4 7
2021 0,02 Q4 7
2020 0,02 Q4 7
2019 7

JCR category quartile history

JCR / JCI quartile by year and category. 1997 and later.

WoS / JCR data covers 1997 onward.

Note: This table shows Clarivate category quartile records from 1997 onward.
Year Category Edition JCR Q (1997+) JCI Q (1997+) Rank
2025 MEDICINE, GENERAL & INTERNAL ESCI Q4 Q4 274/336
2024 MEDICINE, GENERAL & INTERNAL ESCI Q4 Q4 265/332
2023 MEDICINE, GENERAL & INTERNAL ESCI Q4 Q4 269/329
2022 MEDICINE, GENERAL & INTERNAL ESCI Q4
2021 MEDICINE, GENERAL & INTERNAL ESCI Q4
2020 MEDICINE, GENERAL & INTERNAL ESCI Q4